Gus Lawlor

Mr. Lawlor is a General Partner at HealthCare Ventures (HCV), one of the largest healthcare-focused venture capital firms in the world. Mr. Lawlor has 15 years of experience in the biotechnology industry in finance, business development, mergers and acquisitions, and general management. Prior to joining HCV in 2000, he was Chief Operating Officer of LeukoSite (acquired by Millennium Pharmaceuticals), a biotechnology company. Before joining LeukoSite, Mr. Lawlor also served as Chief Financial Officer and Vice President of Corporate Development for Alpha-Beta Technology, and he was previously Chief Financial Officer and Vice President, Business Development, at BioSurface Technology. Mr. Lawlor is a co-founder of Phase Forward (acquired by Oracle ORCL), a company developing Internet-based management tools for conducting clinical trials.

Gus Lawlor is the Chief Operating Officer at Leap Therapeutics, based in United States, North America. With a background in Biotechnology, Gus Lawlor has a rich history of leadership and innovation. Gus Lawlor studied BA unknown @ University of New Hampshire. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.